Table 1 Patient characteristics
n | (%) | ||
|---|---|---|---|
Age, years | Median | 67 | |
Range | 50–76 | ||
Sex, n (%) | Male | 4 | (30.8) |
Female | 9 | (69.2) | |
Smoking status | Never | 6 | (46.2) |
Current/former | 7 | (53.8) | |
ECOG-PS, n (%) | 0 | 5 | (38.5) |
1 | 8 | (61.5) | |
Histology, n (%) | Adenocarcinoma | 13 | (100) |
Clinical stage, n (%) | IVA | 4 | (30.8) |
IVB | 6 | (46.2) | |
Recurrence | 3 | (23.0) | |
EGFR mutation, n (%) | Exon 19 deletion | 4 | (30.8) |
+ T790M | 2 | (15.4) | |
Exon 21 L858R | 4 | (30.8) | |
+ T790M | 2 | (15.4) | |
G719C + S768I | 1 | (7.7) | |
Treatment lines, n (%) | 2nd line | 2 | (15.4) |
3rd line | 5 | (38.5) | |
≥ 4th line | 6 | (46.2) | |